|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.9000 - 1.1600|
|52 Week Range||0.1820 - 1.7400|
|Beta (5Y Monthly)||1.04|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
BioELife Corp. (OTC QB: LITH) (the “Company”) is pleased to announce that Michael Terpin is joining its Advisory Board of external experts to assist the Company in its strategic development. Mr. Michael Terpin brings over 35 years of marketing, public relations, and management experience to help assist BioELife in its communication and social media efforts. Michael Terpin is founder and CEO of Transform Group, whose divisions include Transform PR, a global public relations firm that has served more than 200 clients in the blockchain and high technology fields including Augur, Bancor, Bittrex, Ethereum, Factom, Golem, Kraken, Lisk, Neo, SALT Lending, VideoCoin, and WAX; Transform Events, which includes CoinAgenda, the oldest high-end conference series for investors and blockchain innovators since 2014 (including the first blockchain conferences in the Caribbean), and Transform Strategies, the company’s advisory division.
BioELife Corp. (OTC QB: LITH) (the “Company”) is pleased to announce that William (Bill) Marciniak is joining its Advisory Board of external experts to assist the Company in its strategic development. Mr. Marciniak brings over 35 years of pharmaceutical and manufacturing experience to help BioELife expand its product line, manufacturing and distributor relationships. As a co-founder of RxElite, Mr. Marciniak achieved great success developing and producing albuterol and ipratropium.
BioELife Corp. (OTC QB: LITH) (the “Company”), is pleased to announce that it is forming an Advisory Board of external experts from various specialties to assist the Company in its strategic development. As part of this initiative, the Company is also pleased to announce that a leading chemist, Susan Raffy, will join the new Advisory Board. Ms. Raffy was instrumental in the development of the Company’s BioEDefense Hand Sanitizer, which exceeds the CDC requirements for ethyl alcohol, and is fortified with 50 mg per ounce of CBD.
BioELife Corp. (OTC QB: LITH) (the “Company”), is pleased to announce that it continues to achieve several key objectives for Q1 2020. The Company received a purchase order from a new distributor for the next production run of its entire product line including back-ordered BioEDefense products recently launched to help the world-wide crisis surrounding the Coronavirus (COVID-19). The Company has added the RespiPro Virus Killer nanofiber mask to its ecommerce site while ordering additional inventory for the BioEDefense line of products with expected delivery in April.
BioELife Corp. (OTC QB: LITH) (the “Company”), formerly known as US Lithium Corp., announces that the Company’s chemists and medical advisors have completed their specifications for, and selection of, virus and bacteria protection products including a powerful hand sanitizer fortified with CBD and ultra-protective Nano-Fiber Face Masks. The core of the masks consists of the latest technology using four layers of protection including a nanofiber membrane, RespiPro, with a 60 nano-meter opening that mechanically captures 99.9% of viruses and bacteria.
BioELife Corp. (OTC QB: LITH) (the “Company”), formerly known as US Lithium Corp., is pleased to announce that it has achieved several key milestones during its initial month of operating its CBD business. The Company received a purchase order for its entire first production run of ChiroRub 2000, its proprietary relief rub formulation containing 1,000 mg of CBD per ounce. It is also extending packaging options across several product lines.
US Lithium Corp (OTC QB: LITH) (the “Company”), soon to be renamed BioELife, is pleased to announce that its CBD business has launched its beta ecommerce website, www.bioelife.net. This includes adult CBD gum drops, the Company’s highly concentrated topical 2,000 mg CBD intensive pain cream, premium pre-rolls and flower from its farm partner Hemp Heaven Farms. “BioELife.net offers wholesalers a convenient method to view our expanding product line and order products for distribution,” stated Gregory Rotelli, Chairman of the Board and President of LITH.
US Lithium Corp (OTC QB: LITH) (the “Company”), soon to be renamed BioELife Corp., is pleased to announce that it has completed production and began shipping its latest pain cream, ChiroRub 2000. The proprietary formulation, containing 2,000 mg of CBD, has been doctor and patient tested and is one of the most effective pain relief creams currently available on the market today. ChiroRub 2000 was developed in conjunction with leading physicians, chiropractors, and medical professionals who evaluated and validated the product’s efficacy throughout several developmental phases.
US Lithium Corp (OTC QB: LITH) (the ”Company”) is pleased to announce that its Board of Directors and shareholders have approved an amendment to the Articles of Incorporation changing the name of the corporation from U.S. Lithium Corp. to BioELife Corp. The name change will better reflect the Company’s new strategic focus on the rapidly growing CBD market. The Company expects this action will become effective within the next 30 days. The Company will also be launching a new website and seek a new trading symbol for its common stock immediately after the name change becomes effective.
US Lithium Corp (OTC QB: LITH) (the ”Company”) is pleased to announce that its CBD manufacturing business has been awarded an exclusive purchase and distribution agreement by International Healthcare Network (“IHN”) for at least four of its products. This multiyear agreement is an example of the Company’s focus on securing large distributor arrangements with proven sales and medical organizations.
US Lithium Corp. (OTC QB: LITH) (the ”Company”) is pleased to announce that, effective January 20, 2020, it has acquired four cannabinoid related contracts between Hemp Cloud 9 and four unrelated parties in exchange for 4.7M shares of LITH stock. As a result of these acquisitions the Company will change its primary business from minerals to cannabinoids. The Company also intends to change its name, stock symbol and website within the next 30 days to better reflect this new strategic direction.
US Lithium Corp’s (OTC QB: LITH) recently announced strategic review and evaluation of future prospects and opportunities continues with several potential acquisition candidates identified. “Our Board is committed to maximize shareholder value and, in this light, we have identified accretive acquisition opportunities that would potentially position our company in a high growth industry while also helping improve the lives of individuals,” stated Gregory Rotelli, Chairman of the Board.
US Lithium Corp. (OTC QB: LITH) and its Board of Directors announce that it is conducting a strategic review of the Company in order to identify future prospects and opportunities that could deliver exceptional growth and increase shareholder value. “Our Board continues to be committed to evaluating all options that maximize shareholder value,” said Gregory Rotelli, Chairman of the Board. According to the Brightfield Group, CBD sales in the US are projected to grow from around $600 million in 2018 to $23.7 Billion by 2023, a CAGR in excess of 100%.